Coronavirus Testing Kits Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Type of Test (Molecular v/s Serological), By Use (Multiple Test vs Single Test), By Full Test Time (5 Hours- 12 Hours, 1 Hour- 5 Hours, 15-60 minutes, Less than 15 minutes, 12 Hours - 24 Hours, More than 1 day), By Technology (RT-PCR, Rapid Diagnostic Test, ELISA Test, Others), By Specimen (Nasopharyngeal Specimen, Oropharyngeal Specimen, Blood, Sputum, Others), By Mobility (Stationary and Mobile), By End Use (Public Health Labs, Hospitals, Private or Commercial Labs, Physician Labs, Others), By Region 2021-2031F

  • Industry : Healthcare
  • Pages : 110
  • Published Date : April, 2026

Customization Enquiry

Buy Now
The report will be delivered in PDF format but without printing rights. It is recommended for individual clients for their personal use only.
Single User Licence $4500
The report will be delivered in printable PDF format along with the report’s data excel sheet for internal analysis. It is strongly recommended for a corporate team or an organization where users would like to access the report from multiple locations.!
Multi-User Licence $5500
The report will be delivered in printable PDF format along with the report’s data excel sheet. This license offers free 80 Analyst hours where the client can use TechSci’s research team. It is strongly recommended for an organization which wants to execute short ‘bespoke’ research project related to the scope of the purchased report.!
Custom Research Licence $8000
Media Enquiry
Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2027-2031

Market Size (2025)

USD 17.25 Billion

CAGR (2026-2031)

20.88%

Fastest Growing Segment

Molecular 

Largest Market

North America

Market Size (2031)

USD 53.82 Billion

Market Overview

The Global Coronavirus Testing Kits Market is projected to grow from USD 17.25 Billion in 2025 to USD 53.82 Billion by 2031 at a 20.88% CAGR. Coronavirus testing kits are in vitro diagnostic products designed to detect the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through various methodologies, including molecular assays for viral genetic material or antigen tests for specific viral proteins. The global market's expansion is primarily driven by the persistent imperative for infectious disease surveillance, ongoing global health preparedness efforts, and proactive government initiatives focused on early detection and containment strategies. Furthermore, the continuous evolution of SARS-CoV-2 variants necessitates the development and deployment of updated diagnostic tools.

According to the World Health Organization, in the week of March 9 to 15, 2026, a total of 64,397 samples were tested for SARS-CoV-2 across 80 countries, with 3.3% of these samples testing positive for the virus. A significant challenge that could impede market expansion is the decreasing demand for broad-scale testing as the immediate pandemic response subsides, leading to increased pricing pressure and evolving regulatory landscapes, which can affect manufacturers' profitability and investment in diagnostic infrastructure.

Key Market Drivers

Persistent viral circulation and the emergence of new variants are significant driving forces for the global coronavirus testing kits market. The continuous evolution of SARS-CoV-2 necessitates ongoing surveillance and the development of updated diagnostic tools to accurately detect and differentiate circulating strains. For instance, the highly mutated SARS-CoV-2 BA.3.2 variant, which possesses approximately 70 to 75 substitutions and deletions in its spike protein relative to previous strains, demonstrates the virus's adaptive nature. According to the Centers for Disease Control and Prevention, in March 2026, in the 'Early Detection and Surveillance of the SARS-CoV-2 Variant BA.3.2 — Worldwide, November 2024–February 2026' report, weekly BA.3.2 detections increased to about 30% of sequences reported in Denmark, Germany, and the Netherlands during November 2025 to January 2026. This highlights the sustained need for testing to identify new variants and inform public health responses, maintaining a baseline demand for advanced diagnostic kits.

The rising demand for point-of-care and self-testing solutions also substantially influences the market for coronavirus testing kits. These solutions offer convenience, rapid results, and increased accessibility, enabling individuals to perform tests outside traditional healthcare settings and facilitating quicker isolation and treatment decisions. This shift empowers individuals with greater control over their health monitoring. Reflecting this trend, according to Abbott's Fourth Quarter and Full-Year 2025 Results, released in January 2026, the company's point-of-care diagnostics sales grew 7% in the fourth quarter. This growth underscores the preference for decentralized testing options. Overall, the coronavirus testing kits market continues to navigate evolving demand; according to Abbott, in 2025, the company's COVID-19 testing-related sales were $89 million in the fourth quarter.

Download Free Sample Report

Key Market Challenges

A significant challenge hampering the growth of the Global Coronavirus Testing Kits Market is the decreasing demand for broad-scale testing. As the immediate global pandemic response gradually subsides, the necessity for extensive testing initiatives has diminished, directly resulting in intensified pricing pressure across the market. This reduction in demand and subsequent price erosion directly impacts manufacturers' profitability, curtailing their capacity and willingness to invest in research and development for updated diagnostic tools or expanding production infrastructure. According to MedTech Europe, in 2023, total in vitro diagnostics market revenues across the EU27, EFTA, and the United Kingdom experienced a substantial decline of 20.2% compared with 2022, a contraction overwhelmingly driven by the decrease in COVID-19 testing volumes. This trend underscores how the receding imperative for mass screening negatively affects the financial viability and long-term investment strategies for companies operating in the coronavirus testing kits sector.

Key Market Trends

The global coronavirus testing kits market is experiencing a significant shift towards multiplexed respiratory panels. This trend involves diagnostic tests capable of simultaneously detecting multiple respiratory pathogens, such as SARS-CoV-2, influenza, and respiratory syncytial virus, from a single sample. This advancement addresses the clinical challenge of differentiating infections with similar symptoms, enabling more precise diagnosis and targeted treatment strategies. The integration of these comprehensive panels enhances laboratory efficiency by streamlining testing workflows and reducing the need for multiple, individual assays. For instance, Danaher, Cepheid's parent company, reported approximately 25% year-over-year growth in new product revenue in its Fourth Quarter 2025 earnings call, partly driven by its strategic expansion in multiplex testing offerings.

Another influential trend impacting the market is innovation in less invasive sample collection methods. Historically, nasopharyngeal swabs were standard, but discomfort has fueled demand for alternatives. New methods like saliva-based testing offer greater patient comfort, ease of use, and facilitate self-collection outside traditional healthcare settings. This broadens testing access and potentially increases adherence as emphasis shifts towards convenient diagnostics in endemic phases. The Scientist reported in August 2025 that the US Food and Drug Administration had granted Emergency Use Authorization to a fifth saliva-based test for COVID-19, underscoring the growing acceptance and availability of these less invasive options.

Segmental Insights

The Molecular segment is experiencing rapid growth within the Global Coronavirus Testing Kits Market, particularly driven by Point-of-Care (PoC) molecular tests. This accelerated expansion is attributed to the inherent high accuracy and specificity of molecular diagnostics, which remain the preferred standard for confirmatory diagnosis by regulatory bodies and healthcare professionals. Advancements in miniaturized, user-friendly molecular platforms are facilitating decentralized testing, providing quick, reliable results in diverse settings, thereby expanding accessibility. Furthermore, their adaptability for multiplex respiratory panels enhances their utility beyond single-pathogen detection.

Regional Insights

North America leads the Global Coronavirus Testing Kits Market, primarily due to its robust healthcare infrastructure and widespread testing initiatives. The region benefits significantly from substantial government funding and proactive public health programs designed to combat the pandemic. Additionally, the presence of major market players drives continuous innovation in diagnostic technologies, further supported by the rapid approval of testing tools from regulatory bodies such as the U.S. Food and Drug Administration (FDA). High consumer demand for convenient home testing solutions also contributes considerably to North America's sustained market leadership.

Recent Developments

  • In April 2026, Co-Diagnostics, Inc., a molecular diagnostics company, participated in the ESCMID Global 2026 conference in Munich, Germany. The company utilized this platform to showcase its upcoming Co-Dx PCR platform and its suite of CE-IVD testing solutions for clinical laboratories. This engagement aimed to strengthen relationships with international customers and distributors while expanding the company's global commercial reach for its diagnostic offerings. The Co-Dx PCR platform, which includes home and professional versions along with a mobile application, is currently subject to regulatory review. This event highlighted the company's continued efforts to innovate and expand its presence in the infectious disease diagnostics market, including coronavirus testing kits.
  • In February 2026, Cepheid was selected by the U.S. Centers for Disease Control and Prevention (CDC) as a national collaborator under a federal initiative aimed at accelerating rapid diagnostic technology development and deployment during public health emergencies. This collaboration reinforced Cepheid's leadership in outbreak response and commitment to strengthening national pandemic readiness. The agreement, issued as a multiple-award Indefinite Delivery-Indefinite Quantity contract, allows the CDC to provide Cepheid with early access to outbreak samples, genomic sequences, and critical reference materials. This partnership will support a coordinated national effort to modernize outbreak detection, accelerate diagnostic innovation, and ensure testing remains adaptable to evolving threats, directly impacting the global coronavirus testing kits market by fostering advancements in molecular diagnostics.
  • In November 2025, Co-Diagnostics, Inc., a molecular diagnostics company, announced the initiation of clinical evaluations for its Co-Dx™ PCR Flu A/B, COVID-19, RSV Test Kit. This development marked a significant step towards obtaining 510(k) clearance from the United States Food and Drug Administration (FDA) for the multiplex point-of-care test and the associated Co-Dx PCR Pro™ instrument. The company's leadership highlighted the market's demand for decentralized, gold-standard PCR testing, especially for respiratory infections. This new product aims to bring accurate and reliable diagnostic options to near-patient environments, directly impacting the availability of advanced coronavirus testing kits globally by offering a combined diagnostic solution.
  • In July 2025, researchers at the University of California, Berkeley, unveiled a new low-cost biosensing technology designed to significantly enhance the sensitivity of rapid at-home diagnostic tests. This breakthrough research utilized the "coffee-ring effect," plasmonics, and artificial intelligence to detect disease biomarkers with increased precision within minutes. The innovation could make at-home tests up to 100 times more sensitive for viruses like COVID-19, addressing a key limitation of existing rapid tests. A prototype home testing kit, similar to current COVID-19 kits, was developed with 3D-printed components. This research represents a notable advancement in diagnostic capabilities, potentially leading to more accurate and accessible coronavirus testing kits for consumers.

Key Market Players

  • Abbott Laboratories
  • Roche Diagnostics
  • Thermo Fisher Scientific Inc.
  • Quidel Corporation
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche AG
  • Danaher company
  • Hologic, Inc.

By Type of Test

By Use

By Full Test Time

By Technology

By Specimen

By Mobility

By End Use

By Region

  • Molecular v/s Serological
  • Multiple Test vs Single Test
  • 5 Hours- 12 Hours
  • 1 Hour- 5 Hours
  • 15-60 minutes
  • Less than 15 minutes
  • 12 Hours - 24 Hours
  • More than 1 day
  • RT-PCR
  • Rapid Diagnostic Test
  • ELISA Test
  • Others
  • Nasopharyngeal Specimen
  • Oropharyngeal Specimen
  • Blood
  • Sputum
  • Others
  • Stationary
  • Mobile
  • Public Health Labs
  • Hospitals
  • Private or Commercial Labs
  • Physician Labs
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Coronavirus Testing Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Coronavirus Testing Kits Market, By Type of Test:
  • Molecular v/s Serological
  • Coronavirus Testing Kits Market, By Use:
  • Multiple Test vs Single Test
  • Coronavirus Testing Kits Market, By Full Test Time:
  • 5 Hours- 12 Hours
  • 1 Hour- 5 Hours
  • 15-60 minutes
  • Less than 15 minutes
  • 12 Hours - 24 Hours
  • More than 1 day
  • Coronavirus Testing Kits Market, By Technology:
  • RT-PCR
  • Rapid Diagnostic Test
  • ELISA Test
  • Others
  • Coronavirus Testing Kits Market, By Specimen:
  • Nasopharyngeal Specimen
  • Oropharyngeal Specimen
  • Blood
  • Sputum
  • Others
  • Coronavirus Testing Kits Market, By Mobility:
  • Stationary
  • Mobile
  • Coronavirus Testing Kits Market, By End Use:
  • Public Health Labs
  • Hospitals
  • Private or Commercial Labs
  • Physician Labs
  • Others
  • Coronavirus Testing Kits Market, By Region:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Coronavirus Testing Kits Market.

Available Customizations:

Global Coronavirus Testing Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Coronavirus Testing Kits Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Coronavirus Testing Kits Market

5.    Voice of Customer

5.1.  Brand Awareness (Aided/Unaided)

5.2.  Product Awareness

5.3.  Customer Satisfaction Analysis

5.4.  Pricing Analysis

5.5.  Unmet Needs/Challenges

6.    Global Coronavirus Testing Kits Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Type of Test (Molecular v/s Serological)

6.2.2.     By Use (Multiple Test v/s Single Test)

6.2.3.     By Full Test Time (5 Hours- 12 Hours, 1 Hour- 5 Hours, 15-60 minutes, less than 15 minutes, 12 Hours-24Hours, More Than 1 Days)

6.2.4.     By Technology (RT-PCR, Rapid Diagnostic Test, ELISA Test, Others)

6.2.5.     By Specimen (Nasopharyngeal specimen, Oropharyngeal specimen, Blood, Sputum, others)

6.2.6.     By Mobility (Stationary v/s Mobile)

6.2.7.     By End Use (Public Health Labs, Hospitals, Private or Commercial Labs, Physician Labs, Others)

6.2.8.     By Company (2021)

6.2.9.     By Region

6.3.  Product Market Map

7.    Europe Coronavirus Testing Kits Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Type of Test

7.2.2.     By Use

7.2.3.     By Full Test Time

7.2.4.     By Technology

7.2.5.     By Specimen

7.2.6.     By Mobility

7.2.7.     By End Use

7.2.8.     By Country

7.3.  Europe: Country Analysis

7.3.1.     United Kingdom Coronavirus Testing Kits Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type of Test

7.3.1.2.2.             By Use

7.3.1.2.3.             By Full Test Time

7.3.1.2.4.             By Technology

7.3.1.2.5.             By Specimen

7.3.1.2.6.             By Mobility

7.3.1.2.7.             By End Use

7.3.2.     France Coronavirus Testing Kits Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type of Test

7.3.2.2.2.             By Use

7.3.2.2.3.             By Full Test Time

7.3.2.2.4.             By Technology

7.3.2.2.5.             By Specimen

7.3.2.2.6.             By Mobility

7.3.2.2.7.             By End Use

7.3.3.     Italy Coronavirus Testing Kits Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type of Test

7.3.3.2.2.             By Use

7.3.3.2.3.             By Full Test Time

7.3.3.2.4.             By Technology

7.3.3.2.5.             By Specimen

7.3.3.2.6.             By Mobility

7.3.3.2.7.             By End Use

7.3.4.     Germany Coronavirus Testing Kits Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Type of Test

7.3.4.2.2.             By Use

7.3.4.2.3.             By Full Test Time

7.3.4.2.4.             By Technology

7.3.4.2.5.             By Specimen

7.3.4.2.6.             By Mobility

7.3.4.2.7.             By End Use

7.3.5.     Spain Coronavirus Testing Kits Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Type of Test

7.3.5.2.2.             By Use

7.3.5.2.3.             By Full Test Time

7.3.5.2.4.             By Technology

7.3.5.2.5.             By Specimen

7.3.5.2.6.             By Mobility

7.3.5.2.7.             By End Use

8.    Asia-Pacific Coronavirus Testing Kits Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Type of Test

8.2.2.     By Use

8.2.3.     By Full Test Time

8.2.4.     By Technology

8.2.5.     By Specimen

8.2.6.     By Mobility

8.2.7.     By End Use

8.2.8.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     India Coronavirus Testing Kits Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type of Test

8.3.1.2.2.             By Use

8.3.1.2.3.             By Full Test Time

8.3.1.2.4.             By Technology

8.3.1.2.5.             By Specimen

8.3.1.2.6.             By Mobility

8.3.1.2.7.             By End Use

8.3.2.     China Coronavirus Testing Kits Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type of Test

8.3.2.2.2.             By Use

8.3.2.2.3.             By Full Test Time

8.3.2.2.4.             By Technology

8.3.2.2.5.             By Specimen

8.3.2.2.6.             By Mobility

8.3.2.2.7.             By End Use

8.3.3.     Australia Coronavirus Testing Kits Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type of Test

8.3.3.2.2.             By Use

8.3.3.2.3.             By Full Test Time

8.3.3.2.4.             By Technology

8.3.3.2.5.             By Specimen

8.3.3.2.6.             By Mobility

8.3.3.2.7.             By End Use

8.3.4.     Japan Coronavirus Testing Kits Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type of Test

8.3.4.2.2.             By Use

8.3.4.2.3.             By Full Test Time

8.3.4.2.4.             By Technology

8.3.4.2.5.             By Specimen

8.3.4.2.6.             By Mobility

8.3.4.2.7.             By End Use

8.3.5.     Hong Kong Coronavirus Testing Kits Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type of Test

8.3.5.2.2.             By Use

8.3.5.2.3.             By Full Test Time

8.3.5.2.4.             By Technology

8.3.5.2.5.             By Specimen

8.3.5.2.6.             By Mobility

8.3.5.2.7.             By End Use

8.3.6.     Thailand Coronavirus Testing Kits Market Outlook

8.3.6.1.         Market Size & Forecast

8.3.6.1.1.             By Value

8.3.6.2.         Market Share & Forecast

8.3.6.2.1.             By Type of Test

8.3.6.2.2.             By Use

8.3.6.2.3.             By Full Test Time

8.3.6.2.4.             By Technology

8.3.6.2.5.             By Specimen

8.3.6.2.6.             By Mobility

8.3.6.2.7.             By End Use

8.3.7.     South Korea Coronavirus Testing Kits Market Outlook

8.3.7.1.         Market Size & Forecast

8.3.7.1.1.             By Value

8.3.7.2.         Market Share & Forecast

8.3.7.2.1.             By Type of Test

8.3.7.2.2.             By Use

8.3.7.2.3.             By Full Test Time

8.3.7.2.4.             By Technology

8.3.7.2.5.             By Specimen

8.3.7.2.6.             By Mobility

8.3.7.2.7.             By End Use

8.3.8.     Malaysia Coronavirus Testing Kits Market Outlook

8.3.8.1.         Market Size & Forecast

8.3.8.1.1.             By Value

8.3.8.2.         Market Share & Forecast

8.3.8.2.1.             By Type of Test

8.3.8.2.2.             By Use

8.3.8.2.3.             By Full Test Time

8.3.8.2.4.             By Technology

8.3.8.2.5.             By Specimen

8.3.8.2.6.             By Mobility

8.3.8.2.7.             By End Use

9.    North America Coronavirus Testing Kits Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Type of Test

9.2.2.     By Use

9.2.3.     By Full Test Time

9.2.4.     By Technology

9.2.5.     By Specimen

9.2.6.     By Mobility

9.2.7.     By End Use

9.2.8.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Coronavirus Testing Kits Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type of Test

9.3.1.2.2.             By Use

9.3.1.2.3.             By Full Test Time

9.3.1.2.4.             By Technology

9.3.1.2.5.             By Specimen

9.3.1.2.6.             By Mobility

9.3.1.2.7.             By End Use

9.3.2.     Canada Coronavirus Testing Kits Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type of Test

9.3.2.2.2.             By Use

9.3.2.2.3.             By Full Test Time

9.3.2.2.4.             By Technology

9.3.2.2.5.             By Specimen

9.3.2.2.6.             By Mobility

9.3.2.2.7.             By End Use

9.3.3.     Mexico Coronavirus Testing Kits Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type of Test

9.3.3.2.2.             By Use

9.3.3.2.3.             By Full Test Time

9.3.3.2.4.             By Technology

9.3.3.2.5.             By Specimen

9.3.3.2.6.             By Mobility

9.3.3.2.7.             By End Use

10.  Middle East and Africa Coronavirus Testing Kits Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value & Volume

10.2.              Market Share & Forecast

10.2.1.  By Type of Test

10.2.2.  By Use

10.2.3.  By Full Test Time

10.2.4.  By Technology

10.2.5.  By Specimen

10.2.6.  By Mobility

10.2.7.  By End Use

10.2.8.  By Country

10.3.              MEA: Country Analysis

10.3.1.  Turkey Coronavirus Testing Kits Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type of Test

10.3.1.2.2.           By Use

10.3.1.2.3.           By Full Test Time

10.3.1.2.4.           By Technology

10.3.1.2.5.           By Specimen

10.3.1.2.6.           By Mobility

10.3.1.2.7.           By End Use

10.3.2.  UAE Coronavirus Testing Kits Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type of Test

10.3.2.2.2.           By Use

10.3.2.2.3.           By Full Test Time

10.3.2.2.4.           By Technology

10.3.2.2.5.           By Specimen

10.3.2.2.6.           By Mobility

10.3.2.2.7.           By End Use

10.3.3.  Iran Coronavirus Testing Kits Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type of Test

10.3.3.2.2.           By Use

10.3.3.2.3.           By Full Test Time

10.3.3.2.4.           By Technology

10.3.3.2.5.           By Specimen

10.3.3.2.6.           By Mobility

10.3.3.2.7.           By End Use

10.3.4.  Saudi Arabia Coronavirus Testing Kits Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Type of Test

10.3.4.2.2.           By Use

10.3.4.2.3.           By Full Test Time

10.3.4.2.4.           By Technology

10.3.4.2.5.           By Specimen

10.3.4.2.6.           By Mobility

10.3.4.2.7.           By End Use

10.3.5.  South Africa Coronavirus Testing Kits Market Outlook

10.3.5.1.      Market Size & Forecast

10.3.5.1.1.           By Value

10.3.5.2.      Market Share & Forecast

10.3.5.2.1.           By Type of Test

10.3.5.2.2.           By Use

10.3.5.2.3.           By Full Test Time

10.3.5.2.4.           By Technology

10.3.5.2.5.           By Specimen

10.3.5.2.6.           By Mobility

10.3.5.2.7.           By End Use

11.  South America Coronavirus Testing Kits Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value & Volume

11.2.              Market Share & Forecast

11.2.1.  By Type of Test

11.2.2.  By Use

11.2.3.  By Full Test Time

11.2.4.  By Technology

11.2.5.  By Specimen

11.2.6.  By Mobility

11.2.7.  By End Use

11.2.8.  By Country

11.3.              South America: Country Analysis

11.3.1.  Brazil Coronavirus Testing Kits Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type of Test

11.3.1.2.2.           By Use

11.3.1.2.3.           By Full Test Time

11.3.1.2.4.           By Technology

11.3.1.2.5.           By Specimen

11.3.1.2.6.           By Mobility

11.3.1.2.7.           By End Use

11.3.2.  Argentina Coronavirus Testing Kits Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type of Test

11.3.2.2.2.           By Use

11.3.2.2.3.           By Full Test Time

11.3.2.2.4.           By Technology

11.3.2.2.5.           By Specimen

11.3.2.2.6.           By Mobility

11.3.2.2.7.           By End Use

11.3.3.  Colombia Coronavirus Testing Kits Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type of Test

11.3.3.2.2.           By Use

11.3.3.2.3.           By Full Test Time

11.3.3.2.4.           By Technology

11.3.3.2.5.           By Specimen

11.3.3.2.6.           By Mobility

11.3.3.2.7.           By End Use

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Patent Analysis

14.  Market Trends & Developments

15.  Competitive Landscape

15.1.              Thermo Fisher Scientific Inc.

15.2.              Abbott Laboratories

15.3.              Roche Holdings AG

15.4.              Quest Diagnostics Inc.

15.5.              Quidel Corporation

15.6.              PerkinElmer Inc.

15.7.              QIAGEN NV

15.8.              Becton Dickinson and Company

15.9.              BioMedomics

15.10.            Getein Biotech

15.11.            Sensing Self Ltd

15.12.            Hangzhou Biotest Biotech

15.13.            Beijing Tigsun Diagnostics Co Ltd

15.14.            Biomaxima

15.15.            CTK Biotech

15.16.            Hunan Lituo Biotechnology Co

15.17.            Vivacheck Lab

15.18.            MD Solutions

15.19.            Siemens

15.20.            Seegene Technologies

15.21.            FastSense Diagnostics

16.  Strategic Recommendations

Figures and Tables

Figure 1: Global Coronavirus Testing Kits Market Size, By Value (USD Million) & Volume (Million Units), 2017-2027F

Figure 2: Global Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 3: Global Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 4: Global Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 5: Global Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 6: Global Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 7: Global Coronavirus Testing Kits Market Share, By Mobility, By Value, 2017-2027F

Figure 8: Global Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 9: Global Coronavirus Testing Kits Market Share, By Region, By Value, 2017-2027F

Figure 10: Global Coronavirus Testing Kits Market Share, By Company, By Value, 2021

Figure 11: Global Coronavirus Testing Kits Market Map, By Type of Test, Market Size (USD Million) & Growth Rate (%), 2021

Figure 12: Global Coronavirus Testing Kits Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021

Figure 13: Europe Coronavirus Testing Kits Market Size, By Value (USD Million) & Volume (Million Units), 2017-2027F

Figure 14: Europe Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 15: Europe Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 16: Europe Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 17: Europe Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 18: Europe Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 19: Europe Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 20: Europe Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 21: Europe Coronavirus Testing Kits Market Share, By Country, By Value, 2017-2027F

Figure 22: France Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 23: United Kingdom Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 24:  United Kingdom Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 25:  United Kingdom Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 26:  United Kingdom Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 27:  United Kingdom Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 28:  United Kingdom Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 29:  United Kingdom Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 30: France Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 31: France Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 32: France Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 33: France Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 34: France Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 35: France Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 36: France Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 37: France Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 38: Italy Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 39: Italy Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 40: Italy Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 41: Italy Coronavirus Testing Kit Market Share, By Full Time Test, By Value, 2017-2027F

Figure 42: Italy Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 43: Italy Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 44: Italy Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 45: Italy Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 46: Germany Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 47: Germany Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 48: Germany Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 49: Germany Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 50: Germany Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 51: Germany Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 52: Germany Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 53: Germany Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 54: Spain Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 55: Spain Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 56: Spain Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 57: Spain Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 58: Spain Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 59: Spain Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 60: Spain Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 61: Spain Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 62: Asia-Pacific Coronavirus Testing Kits Market Size, By Value (USD Million) & Volume (Million Units), 2017-2027F

Figure 63: Asia-Pacific Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 64: Asia-Pacific Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 65: Asia-Pacific Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 66: Asia-Pacific Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 67: Asia-Pacific Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 68: Asia-Pacific Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 69: Asia-Pacific Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 70: Asia-Pacific Coronavirus Testing Kits Market Share, By Country, By Value, 2017-2027F

Figure 71: India Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 72: India Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 73: India Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 74: India Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 75: India Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 76: India Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 77: India Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 78: India Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 79: China Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 80: China Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 81: China Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 82: China Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 83: China Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 84: China Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 85: China Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 86: China Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 87: Australia Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 88: Australia Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 89: Australia Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 90: Australia Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 91: Australia Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 92: Australia Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 93: Australia Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 94: Australia Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 95: Japan Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 96: Japan Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 97: Japan Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 98: Japan Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 99: Japan Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 100: Japan Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 101: Japan Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 102: Japan Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 103: Hong Kong Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 104: Hong Kong Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 105: Hong Kong Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 106: Hong Kong Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 107: Hong Kong Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 108: Hong Kong Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 109: Hong Kong Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 110: Hong Kong Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 111: Thailand Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 112: Thailand Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 113: Thailand Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 114: Thailand Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 115: Thailand Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 116: Thailand Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 117: Thailand Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 118: Thailand Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 119: South Korea Coronavirus Testing Kits Market Share, By Value (USD Million), 2017-2027F

Figure 120: South Korea Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 121: South Korea Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 122: South Korea Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 123: South Korea Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 124: South Korea Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 125: South Korea Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 126: South Korea Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 127: Malaysia Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 128: Malaysia Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 129: Malaysia Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 130: Malaysia Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 131: Malaysia Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 132: Malaysia Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 133: Malaysia Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 134: Malaysia Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 135: North America Coronavirus Testing Kits Market Size, By Value (USD Million) & Volume (Million Units), 2017-2027F

Figure 136: North America Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 137: North America Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 138: North America Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 139: North America Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 140: North America Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 141: North America Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 142: North America Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 143: North America Coronavirus Testing Kits Market Share, By Country, By Value, 2017-2027F

Figure 145: United States Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 146: United States Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 147: United States Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 148: United States Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 149: United States Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 150: United States Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 151: United States Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 152: United States Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 153: Canada Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 154: Canada Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 155: Canada Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 156: Canada Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 157: Canada Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 158: Canada Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 159: Canada Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 160: Canada Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 161: Mexico Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 162: Mexico Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 163: Mexico Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 164: Mexico Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 165: Mexico Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 166: Mexico Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 167: Mexico Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 168: Mexico Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 169: Middle East & Africa Coronavirus Testing Kits Market Size, By Value (USD Million) & Volume (Million Units), 2017-2027F

Figure 170: Middle East & Africa Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 171: Middle East & Africa Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 172: Middle East & Africa Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 173: Middle East & Africa Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 174: Middle East & Africa Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 175: Middle East & Africa Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 176: Middle East & Africa Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 177: Middle East & Africa Coronavirus Testing Kits Market Share, By Country, By Value, 2017-2027F

Figure 178: Turkey Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 179: Turkey Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 180: Turkey Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 181: Turkey Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 182: Turkey Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 183: Turkey Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 184: Turkey Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 185: Turkey Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 186: UAE Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 187: UAE Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 188: UAE Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 189: UAE Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 190: UAE Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 191: UAE Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 192: UAE Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 193: UAE Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 194: Iran Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 195: Iran Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 196: Iran Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 197: Iran Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 198: Iran Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 199: Iran Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 200: Iran Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 201: Iran Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 202: Saudi Arabia Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 203: Saudi Arabia Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 204: Saudi Arabia Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 205: Saudi Arabia Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 206: Saudi Arabia Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 207: Saudi Arabia Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 208: Saudi Arabia Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 209: Saudi Arabia Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 210: South Africa Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 211: South Africa Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 212: South Africa Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 213: South Africa Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 214: South Africa Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 215: South Africa Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 216: South Africa Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 217: South Africa Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 218: South America Coronavirus Testing Kits Market Size, By Value (USD Million) & Volume (Million Units), 2017-2027F

Figure 219: South America Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 220: South America Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 221: South America Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 222: South America Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 223: South America Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 224: South America Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 225: South America Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 226: South America Coronavirus Testing Kits Market Share, By Country, By Value, 2017-2027F

Figure 227: Brazil Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 228: Brazil Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 229: Brazil Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 230: Brazil Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 231: Brazil Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 232: Brazil Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 233: Brazil Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 234: Brazil Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 235: Argentina Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 236: Argentina Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 237: Argentina Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 238: Argentina Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 239: Argentina Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 240: Argentina Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 241: Argentina Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 242: Argentina Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F

Figure 243: Colombia Coronavirus Testing Kits Market Size, By Value (USD Million), 2017-2027F

Figure 244: Colombia Coronavirus Testing Kits Market Share, By Type of Test, By Value, 2017-2027F

Figure 245: Colombia Coronavirus Testing Kits Market Share, By Use, By Value, 2017-2027F

Figure 246: Colombia Coronavirus Testing Kits Market Share, By Full Time Test, By Value, 2017-2027F

Figure 247: Colombia Coronavirus Testing Kits Market Share, By Technology, By Value, 2017-2027F

Figure 248: Colombia Coronavirus Testing Kits Market Share, By Specimen, By Value, 2017-2027F

Figure 249: Colombia Coronavirus Testing Kits Market Share, By Mobility by Value, 2017-2027F

Figure 250: Colombia Coronavirus Testing Kits Market Share, By End-Use, By Value, 2017-2027F
Frequently asked questions

Frequently asked questions

The market size of the Global Coronavirus Testing Kits Market was estimated to be USD 17.25 Billion in 2025.

North America is the dominating region in the Global Coronavirus Testing Kits Market.

Molecular  segment is the fastest growing segment in the Global Coronavirus Testing Kits Market.

The Global Coronavirus Testing Kits Market is expected to grow at 20.88% between 2026 to 2031.

Related Reports
Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.